Sector
PharmaceuticalsOpen
₹0.51Prev. Close
₹0.49Turnover(Lac.)
₹0Day's High
₹0.51Day's Low
₹0.5152 Week's High
₹052 Week's Low
₹0Book Value
₹4.82Face Value
₹10Mkt Cap (₹ Cr.)
0.21P/E
0EPS
0Divi. Yield
0No Record Found
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
Equity Capital  | 4.12  | 4.12  | 4.12  | 4.12  | 
Preference Capital  | 0  | 0  | 0  | 0  | 
Reserves  | -2.13  | -2.09  | -2.05  | -2.02  | 
Net Worth  | 1.99  | 2.03  | 2.07  | 2.1  | 
Minority Interest  | 
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
Revenue  | 0  | 0  | 0  | 0  | 
yoy growth (%)  | 0  | 0  | 0  | 0  | 
Raw materials  | 0  | 0  | 0  | 0  | 
As % of sales  | 0  | 0  | 0  | 0  | 
Employee costs  | 0  | 0  | 0  | 0  | 
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
Profit before tax  | -0.04  | -0.03  | -0.03  | -0.02  | 
Depreciation  | 0  | 0  | 0  | 0  | 
Tax paid  | 0  | 0  | 0  | 0  | 
Working capital  | -0.04  | -0.04  | -0.02  | -0.02  | 
Other operating items  | 
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | 
|---|---|---|---|---|
Growth matrix (%)  | ||||
Revenue growth  | 0  | 0  | 0  | 0  | 
Op profit growth  | 1.71  | -6.03  | 43.03  | 42.69  | 
EBIT growth  | 7.75  | 18.33  | 20.38  | 19.33  | 
Net profit growth  | 7.75  | 18.33  | 20.38  | 19.33  | 
No Record Found
Company Name  | LTP (₹)  | P/E  (%)  | Mkt.Cap  (₹Cr.)  | NP Qtr (₹Cr.)  | Div.Yield  (%)  | Sales Qtr  (₹.Cr)  | Book Value (₹)  | 
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA  | 1,707.25  | 82.24 | 4,09,626.46 | 753.53 | 0.94 | 5,566.68 | 101.44 | 
Divis Laboratories Ltd DIVISLAB  | 6,805.65  | 77.34 | 1,80,668.62 | 557 | 0.44 | 2,357 | 561.08 | 
Torrent Pharmaceuticals Ltd TORNTPHARM  | 3,628.15  | 61.77 | 1,22,787.57 | 551 | 0.17 | 2,567 | 224.34 | 
Cipla Ltd CIPLA  | 1,511.6  | 23.49 | 1,22,102.7 | 1,210.53 | 1.06 | 4,495.16 | 411.56 | 
Dr Reddys Laboratories Ltd DRREDDY  | 1,196.45  | 18.5 | 99,857.36 | 387.3 | 0.67 | 4,602.9 | 377.57 | 
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman
Dharamchand Shah
Director
Sunil D Shah
Director
Sumedh Shah
Director
Dayanand Naik
Director
Umesh Patil
Director
Rajendra Petare
1393 Peth Bhag,
High School Road,
Maharashtra - 416416
Tel: 91-233-373886/374467/323310
Website: -
Email: vardhaman.lab@gmail.com
C-13 Pannalal Silk,
Mills Cmpd LBS Marg, Bhandup West,
Mumbai - 400 078
Tel: 91-022-25963838
Website: www.linkintime.co.in
Email: rnt.helpdesk@linkintime.co.in/mumbai@linkintime.co.in
Summary
Vardhaman Laboratories Ltd was incorporated on 24th April, 1985 under the Companies Act, 1956, in the State of Maharashtra as Vardhaman Laboratories Private Limited ans subsequently converted into a P...
Read More
Reports by Vardhaman Laboratories Ltd
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.